Acute intestinal intussusception in children: Diagnosis, epidemiology and on time monitoring of the anti-rotavirus vaccines;Invagination intestinale aiguë de l'enfant: Diagnostic, épidémiologie et surveillance à l'heure des vaccins contre le rotavirus

Medecine Therapeutique Pediatrie

Volumn 9, Issue SPEC. ISS., 2006, Pages 29-34

  Minodier, Philippe ^a   Merrot, Thierry ^a  

^a HÔPITAL NORD   (France)

Author keywords

[No Author keywords available]

Indexed keywords

VACCINE;

CHILD CARE; HUMAN; INCIDENCE; INFECTION CONTROL; INTESTINE ISCHEMIA; REVIEW; ROTAVIRUS; VACCINATION; VIRUS INFECTION;

EID: 33751099841     PISSN: 12865494     EISSN: None     Source Type: Journal    
DOI: 10.1684/mtp.2006.0012     Document Type: Review

References (19)

1. Bisset III GS, Kirks DR. Intussusception in infants and children: diagnosis and treatment. Radiology 1988; 168: 141-5.
2. Sorantin E, Lindbichler F. Management of intussusception. Eur Radiol 2004; 14: L146-L154.
3. Bines JE, Ivanoff B. Acute intussusception in infants and young children: incidence, clinical presentation and management: a global perspective. WHO/V&B/02.19. Geneva: World Health Organization, Department of Vaccines and Biologicals; 2002. http://www.who.int/vaccines-docunnents/DocsPDF02/www640.pdf.
4. Seksik N. Invagination intestinale aiguë de l'enfant: analyse de 92 observations admises au CHU Nord de Marseille de 1996 à 2004 [thèse], Marseille: université de la Méditerranée; 2005.
5. Parashar UD, Holman RC, Cummings KC, et al. Trends in intussusception-associated hospitalizations and deaths among US infants. Pediatrics 2000; 106: 1413-21.
6. Bines JE, Kohl KS, Forster J, et al. Acute intussusception in infants and children as an adverse event following immunization: case definition and guidelines of data collection, analysis and presentation. Vaccine 2004; 22: 569-74.
7. Tapiainen T, Bär G, Bonhoffer J, Heininger U. Evaluation of the Brighton Collaboration case definition of acute intussusception during active surveillance. Vaccine 2006; 24: 1483-7.
8. O'Ryan M, Lucero Y, Pena A, Valenzuela MT. Two year review of intestinal intussusception in six large public hospitals of Santiago, Chile. Pediatr Infect Dis J 2003; 22: 717-21.
9. Fischer TK, Bihrmann K, Perch M, et al. Intussusception in early childhood: a cohort study of 1,7 million children. Pediatrics 2004; 114: 782-5.
10. Chang HGH, Smith PF, Ackelsberg J, Morse DL, Glass RI. Intussusception, rotavirus diarrhea, and rotavirus vaccine use among children in New York State. Pediatrics 2001; 108: 54-60.
11. Iskander J, Haber P, Murphy TV, Chen RT, Sabin M. Suspension of rotavirus vaccine after reports of intussusception. United States, 1999. MMWR Weekly 2004; 53: 786-9.
12. Murphy TV, Gargiullo PM, Massoudi MS, et al. Intussusception among infants after an oral rotavirus vaccine. N Engl J Med 2001; 344: 564-72.
13. Murphy TV, Smith PJ, Gargiullo PM, Schwartz B. The first rotavirus vaccine and intussusception: epidemiological studies and policy decisions. J Infect Dis 2003; 187: 1309-13.
14. Vesikari T, Karvonen A, Korhonen T, et al. Safety and immunogenicity of RIX4414 live attenuated human rotavirus vaccine in adults, toddlers and previously uninfected infants. Vaccine 2004; 22: 2836-42.
15. Vesikari T, Karvonen A, Puustinen L, et al. Efficacy of RIX4414 live attenuated human rotavirus vaccine in Finnish infants. Pediatr Infect Dis J 2004; 23: 937-43.
16. Phua KB, Quak SH, Lee BW, et al. Evaluation of RIX4414, a live, attenuated rotavirus vaccine, in a randomized, double-blind, placebo-controlled phase 2 trial involving 2464 Singaporean infants. J Infect Dis 2005; 192: S6-16.
17. Heaton PM, Goveia MG, Miller JM, Offit P, Clark HF. Development of a pentavalent rotavirus vaccine against prevalent serotypes of rotavirus gastroenteritis. J Infect Dis 2005; 192: S17-S21.
18. Ruiz-Palacios GM, Pérez-Schael I, Velazquez FR, et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritris. N Engl J Med 2006; 354: 11-22.
19. Vesikari T, Matson DO, Dennehy P, et al. Safety and efficacy of a pentavalent human-bocine (WC3) reassortant rotavirus vaccine. N Engt J Med 2006; 354: 23-33.